Telehealth and Intervention Stigma: Patient Perspectives About Flexible Opioid Use Disorder Treatment Delivery

<b>Background:</b> While medications for opioid use disorder (MOUD) are widely considered the "gold standard" of opioid use disorder (OUD) care, more than 80% of people with OUD receive no treatment; of those who do receive care, less than half receive MOUD. Stigma is a major impediment to both OUD treatment in general and MOUD in particular. Recent scholarship has documented how particular medical interventions can themselves become the target of "intervention stigma" distinct from the "condition stigma" often attached to stigmatized medical conditions or patient populations. Telehealth, which has become a more viable and popular option for delivering MOUD since the onset of the COVID-19 pandemic, can potentially alleviate some of the stigma patients face when accessing in-person care, but also may itself be subject to particular forms of stigma. While telehealth offers an opportunity to provide lower-barrier, more accessible care, its uptake as a treatment modality depends on its acceptability to patients and providers. <b>Methods:</b> This qualitative, interview-based study of 25 patients with OUD in Philadelphia, Pennsylvania, explores patient experiences with and perceptions of OUD treatment and telehealth for MOUD, with a focus on how patients compare different treatment modalities and their beliefs about the effectiveness and appropriateness of telehealth for MOUD. <b>Results:</b> We explore how ideas about drug dependence and treatment inform opinions about MOUD and telehealth, generating a distinct form of "intervention stigma" around this modality of care. We show how assumptions about people who use drugs combine with the technical affordances and limitations of telehealth to compound stigma above and beyond the stigma directed at MOUD generally. <b>Conclusion:</b> While previous research about telehealth MOUD suggests that it is as effective as in-person care and reduces important barriers to treatment, this form of intervention stigma may negatively impact patient perceptions about its appropriateness and effectiveness.

Authors

Institutions

Publication Details

Journal
Substance Use &amp Addiction Journal
Published
2026-02-23
DOI
https://doi.org/10.1177/29767342261419608
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Telehealth and Intervention Stigma: Patient Perspectives About Flexible Opioid Use Disorder Treatment Delivery

Helena Addison, Emilio Ambrosio Flores, Shoshana V. Aronowitz, Naomi Zucker et al.
Substance Use &amp Addiction Journal
Opioid Use Disorder Treatment
article

Telehealth and Intervention Stigma: Patient Perspectives About Flexible Opioid Use Disorder Treatment Delivery

Helena Addison, Emilio Ambrosio Flores, Shoshana V. Aronowitz, Naomi Zucker, David S. Mandell, Justin T. Clapp
article en

Abstract

<b>Background:</b> While medications for opioid use disorder (MOUD) are widely considered the "gold standard" of opioid use disorder (OUD) care, more than 80% of people with OUD receive no treatment; of those who do receive care, less than half receive MOUD. Stigma is a major impediment to both OUD treatment in general and MOUD in particular. Recent scholarship has documented how particular medical interventions can themselves become the target of "intervention stigma" distinct from the "condition stigma" often attached to stigmatized medical conditions or patient populations. Telehealth, which has become a more viable and popular option for delivering MOUD since the onset of the COVID-19 pandemic, can potentially alleviate some of the stigma patients face when accessing in-person care, but also may itself be subject to particular forms of stigma. While telehealth offers an opportunity to provide lower-barrier, more accessible care, its uptake as a treatment modality depends on its acceptability to patients and providers. <b>Methods:</b> This qualitative, interview-based study of 25 patients with OUD in Philadelphia, Pennsylvania, explores patient experiences with and perceptions of OUD treatment and telehealth for MOUD, with a focus on how patients compare different treatment modalities and their beliefs about the effectiveness and appropriateness of telehealth for MOUD. <b>Results:</b> We explore how ideas about drug dependence and treatment inform opinions about MOUD and telehealth, generating a distinct form of "intervention stigma" around this modality of care. We show how assumptions about people who use drugs combine with the technical affordances and limitations of telehealth to compound stigma above and beyond the stigma directed at MOUD generally. <b>Conclusion:</b> While previous research about telehealth MOUD suggests that it is as effective as in-person care and reduces important barriers to treatment, this form of intervention stigma may negatively impact patient perceptions about its appropriateness and effectiveness.

Substance Use &amp Addiction Journal
Yale University (US), Penn Center for AIDS Research (US), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 50%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.